title: European symposium on precision medicine in allergy and airways diseases: report of the European Union parliament symposium (October 14, 2015).
abstract: On 14 October 2015, the European Academy of Allergy and Clinical Immunology (EAACI), the European Rhinologic Society (ERS) and the European Medical Association (EMA) organized a symposium in the European Parliament in Brussels on Precision Medicine in Allergy and Airways Diseases, hosted by MEP David Borrelli and with active participation of the European Respiratory Society (ERS), the European Federations of Allergy and Airways Diseases Patients Associations (EFA), the Global Allergy and Asthma European Network (Ga2len), Allergic Rhinitis and Its Impact on Asthma (ARIA) and the Respiratory Effectiveness Group (REG). MEP Sirpa Pietikainen, Chair of the European Parliament Interest Group on Allergy and Asthma, underlined the importance of the need for a better diagnostic and therapeutic approach for patients with Allergies and Chronic Airways Diseases, and encouraged a joint initiative to control the epidemic of Allergy and Asthma in Europe. The socio-economic impact of allergies and chronic airways diseases cannot be underestimated, as they represent the most frequently diagnosed chronic non-communicable diseases in the EU. Despite the fact that 30% of the total European population is nowadays suffering from allergies and asthma, more than half of these patients are deprived from adequate diagnosis and treatment. Precision Medicine represents a novel approach in medicine, embracing 4 key features: personalized care based on molecular, immunologic and functional endotyping of the disease, with participation of the patient in the decision making process of therapeutic actions, and taking into account predictive and preventive aspects of the treatment. Implementation of Precision Medicine into clinical practice may help to achieve the arrest of the Epidemic of Allergies and Chronic Airways Diseases. This report summarizes the key messages delivered during the symposium by the speakers, including the EU Commissioner for Health and Food Safety Vitenys Andriukaitis. The Commissioner underscored the need for optimal patient care in Europe, supporting joint action plans for disease prevention, patient empowerment and cost-effective treatment strategies leading to a better health status of European citizens.
authors.forename: A
authors.initials: A
authors.lastname: Muraro
authors.forename: W J
authors.initials: WJ
authors.lastname: Fokkens
authors.forename: S
authors.initials: S
authors.lastname: Pietikainen
authors.forename: D
authors.initials: D
authors.lastname: Borrelli
authors.forename: I
authors.initials: I
authors.lastname: Agache
authors.forename: J
authors.initials: J
authors.lastname: Bousquet
authors.forename: V
authors.initials: V
authors.lastname: Costigliola
authors.forename: G
authors.initials: G
authors.lastname: Joos
authors.forename: V J
authors.initials: VJ
authors.lastname: Lund
authors.forename: L K
authors.initials: LK
authors.lastname: Poulsen
authors.forename: D
authors.initials: D
authors.lastname: Price
authors.forename: C
authors.initials: C
authors.lastname: Rolland
authors.forename: T
authors.initials: T
authors.lastname: Zuberbier
authors.forename: P W
authors.initials: PW
authors.lastname: Hellings
mesh_terms: D005060:Europe; D006801:Humans; D006967:Hypersensitivity / Q000628:therapy*; D057285:Precision Medicine; D012140:Respiratory Tract Diseases / Q000628:therapy*